1Bowie A, O′Neill LA . Oxidative stress and nuclear factor-KB activation: a reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol, 2000,59:13-23.
2Liu SF, Ye X, Malik AB. Inhibition of NF-KB activation by pyrrolidine dithiocarbamate prevents in vivo expression of proinflammatory genes. Circulation, 1999,100 : 1330-1337.
3Dollner H, Vatten L, Linnebo I, et al. Inflammatory mediators in umbilical plasma from neonates who develop early-onset sepsis. Biol Neonate, 2001,80:41-47.
4Silveira RC, Procianoy BS. Evaluation of intedeukin-6, tumour necrosis faetor-adpha and intedeukin-1beta for early diagnosis of neonatal sepsis. Acta Paediatr, 1999,88:647-650.
5Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol,1994,10:405-455.
6Mancuso C, Cusumano V, Genovese F, et al. Role of interleukin 12 in experimental neonatal sepsis cauaed by group B streptococci.Infect-Immun, 1997,65:3731-3735.
7Patrick A, Baltimore B, Baltimore D. NF-KB:ten years after. Cell,1996,87 : 13-20.
8O′Neill LA, Kahschmidt C. NF-kB : a crucial transcription factor for glial and neuronal cell function. Trends Neurosci, 1997, 20:252-258.
9Blackwell TS, Holden EP, Blackwell TR, et al. Cytokine-induced neutrophil chemoattractant mediates neutrophilic alveolitis in rats:association with nuclear factor kappa B activation. Am J Respir Cell Mol Bid, 1994,11:464-472.
10William B, Ha TZ, Li CF, et al. Early activation of pulmonary nuclear factorkB and nuclear factor interleukin-6 in polymicrobial sepsis. J Trauma. 1999.46: 590-596.
